A new study finds ketamine as effective as electroconvulsive therapy (without its major side effects) for the treatment of nonpsychotic, treatment-resistant depression.
Researchers in Boston found that among those who got ketamine, 55 percent had improvements in their symptoms in six months. For comparison, other treatments was 41 percent.
Researchers at Mass General Brigham have conducted a groundbreaking study that demonstrates the effectiveness of subanesthetic intravenous ketamine as a